Literature DB >> 21205070

Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2.

Masayuki Kamino1, Michiko Kishida, Toshiro Kibe, Kyoko Ikoma, Mikio Iijima, Hirofumi Hirano, Mai Tokudome, Lin Chen, Chihaya Koriyama, Katsushi Yamada, Kazunori Arita, Shosei Kishida.   

Abstract

Wnts are secreted ligands that consist of 19 members in humans, regulate cell proliferation, differentiation, motility and fate in many stages including the embryonic stage and tumorigenesis. Wnts bind to cell surface receptors named Frizzleds and LRPs, and transduce their signals through β-catenin-dependent and -independent intracellular pathways. Gliomas are one of the most common intracranial tumors. Gliomas exhibit a progression associated with widespread infiltration into surrounding neuronal tissues. However, the molecular mechanisms that stimulate the invasion of glioma cells are not fully understood. We established two cell lines from human glioma cases and analyzed the expression of all Wnt and Frizzled members in these cell lines and other well-known glioma cell lines by real-time PCR study. The mRNA of Wnt-5a and -7b and Frizzled-2, -6 and -7 were overexpressed in glioma cells. The elevation of Wnt-5a expression was most remarkable. Although Wnt-5a is reported to have oncogenic and antioncogenic activity in several cancers, the role of Wnt-5a signaling in human glioma cells remains unclear. Immunohistochemical study also revealed high expression of Wnt-5a in 26 (79%) of 33 human glioma cases. The positivity of Wnt-5a expression was correlated with the clinical grade. Knockdown of Wnt-5a expression suppressed migration, invasion and expression of matrix metalloproteinase-2 of glioma cells. Reciprocally, treatment with purified Wnt-5a ligand resulted in stimulation of cell migration and invasion. MMP-2 inhibitor suppressed the Wnt-5a-dependent invasion of U251 cells. These results suggested that Wnt-5a is not only a prognostic factor but also a therapeutic target molecule in gliomas for preventing tumor cell infiltration.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21205070     DOI: 10.1111/j.1349-7006.2010.01815.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  51 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.

Authors:  Damián E Berardi; Carolina Flumian; Paola B Campodónico; Alejandro J Urtreger; María I Diaz Bessone; Andrea N Motter; Elisa D Bal de Kier Joffé; Eduardo F Farias; Laura B Todaro
Journal:  Cell Oncol (Dordr)       Date:  2015-06-05       Impact factor: 6.730

3.  Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Authors:  R Jain; L Poisson; J Narang; L Scarpace; M L Rosenblum; S Rempel; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

4.  Prolonged overexpression of Wnt10b induces epidermal keratinocyte transformation through activating EGF pathway.

Authors:  Mingxing Lei; Xiangdong Lai; Xiufeng Bai; Weiming Qiu; Tian Yang; Xiaoling Liao; Cheng-Ming Chuong; Li Yang; Xiaohua Lian; Julia Li Zhong
Journal:  Histochem Cell Biol       Date:  2015-05-21       Impact factor: 4.304

Review 5.  Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry.

Authors:  Kimberly A Mulligan; Benjamin N R Cheyette
Journal:  Mol Neuropsychiatry       Date:  2017-01-13

6.  Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.

Authors:  Marta Portela; Varun Venkataramani; Natasha Fahey-Lozano; Esther Seco; Maria Losada-Perez; Frank Winkler; Sergio Casas-Tintó
Journal:  PLoS Biol       Date:  2019-12-17       Impact factor: 8.029

Review 7.  Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk.

Authors:  Indranil Paul; Seemana Bhattacharya; Anirban Chatterjee; Mrinal K Ghosh
Journal:  Genes Cancer       Date:  2013-11

8.  Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.

Authors:  Sophia Doll; Anatoly Urisman; Juan A Oses-Prieto; David Arnott; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2016-11-10       Impact factor: 5.911

9.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

Review 10.  WNT signaling in glioblastoma and therapeutic opportunities.

Authors:  Yeri Lee; Jin-Ku Lee; Sun Hee Ahn; Jeongwu Lee; Do-Hyun Nam
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.